About Decapinol™
Decapinol is registered in the EU and in the USA as
a medical device.
How Decapinol works
Decapinol has a novel mode of action. It works at the interface
between dental plaque bacteria and the surface of the teeth and
gums. Decapinol reduces adherence of the bacterial plaque to the
oral surfaces, and also of bacteria to each other1. This
mode of action not only reduces the formation of new plaque but
also breaks up existing plaque, making it easier to remove with
normal toothbrushing. By reducing the presence of plaque, the amount
of bacterial toxins released into the gum is reduced. The end result
is a reduction in both plaque and gingivitis.
Decapinol’s efficacy and safety in the reduction of plaque
and treatment of gingivitis has been demonstrated in extensive clinical
studies carried out by leading periodontists.
Not an anti-bacterial agent
Decapinol’s mode of action is different from that of other
therapeutic agents for dental plaque control and the treatment of
gingivitis, which work by killing oral bacteria. Decapinol has low
antimicrobial activity against the normal primary colonising oral
flora. Decapinol provides an intelligent and desirable method of
treating gingivitis, in which the ecological balance of oral flora
is maintained, avoiding indiscriminate killing of all oral bacteria.
Lack of dark staining
Decapinol does not cause the semi-permanent dark tooth-staining
that occurs with chlorhexidine, and which often restricts the duration
of use of chlorhexidine products in the treatment and prevention
of gingivitis. Chlorhexidine is the key ingredient of most anti-gingivitis
products currently recommended by dentists.
Lack of interaction with toothpaste
The efficacy of Decapinol is not reduced by SLS, a common ingredient
of toothpaste, unlike chlorhexidine2.
How to use Decapinol
Twice a day after normal toothbrushing, rinse the mouth with 10ml
of Decapinol mouthwash for around 1 minute.
Frost & Sullivan has awarded
their prestigious Oral and Dental Care Product of the Year
award to Decapinol (2006)
| 1 |
Klinge B, Matsson L, Attstrom R
et al. Effect of local application of delmopinol hydrochloride
on developing and early established supragingival plaque in
humans. J Clin Periodontol 1996; 23: 542-547
|
| 2 |
Barkvoll P, Rölla G, Svendsen AK. Interaction between
chlorhexidine digluconate and sodium lauryl sulphate in vivo.
J Clin Periodontol 1989; 16:593-595 |
|
